Skip to main content

Bipolar Disorder

  • Living reference work entry
  • First Online:
Tasman’s Psychiatry

Abstract

The bipolar disorders are a group of severe mood disorders that together afflict about 3% of the global population. They are characterized by the presence of both manic or hypomanic episodes and depressive episodes. They are divided into type I disorder, which is defined by the occurrence of severe manic episodes; type II disorder in which the depressive episode occurs with hypomania but not mania; and cyclothymia, in which subsyndromal hypomanic and depressions are present. These disorders are highly familial but environmental factors are also important. Comorbidity with medical and psychiatric conditions, particularly alcohol use disorder, is common. Treatments include the use of mood stabilizers such as lithium and some anticonvulsants. The use of agents such as antipsychotics and antidepressants are common. Prognosis is guarded for many, but for some patients there is restitutio ad integrum between episodes, and some are highly creative and productive.

This chapter is an update from the 4th edition. Previous edition author was Rif S. El-Mallakh

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  • Al Risi, K., Al Maqbali, M., Asiri, W. A., Al & Sinawi, H. (2018). Rate of Tobacco Smoking Among Psychiatric Outpatients Attending a Tertiary Care Hospital in Oman: A Cross-sectional Study. Oman Med J, 33(3), 224–228. https://doi.org/10.5001/omj.2018.41

  • Ali Z, El-Mallakh RS (2021) Lithium nephropathy and renal microcysts. Current Psychiatry (in press).

    Google Scholar 

  • Angst, J., Ajdacic-Gross, V., & Rössler, W. (2020). Bipolar disorders in ICD-11: Current status and strengths. International Journal of Bipolar Disorers, 8, 3.

    Google Scholar 

  • Baldessarini, R. J., Tondo, L., & Vazquez, G. H. (2019). Pharmacologic treatment of adult bipolar disorder. Bipolar Disorders, 24(2), 198–217.

    CAS  Google Scholar 

  • Ball, J. R., Mitchell, P. B., & Corry, J. C., et al. (2006). A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. Journal of Clinical Psychiatry, 67, 277–286.

    Google Scholar 

  • Bauer, M. S., McBride, L., & Williford, W. O., et al. (2006a). Collaborative care for bipolar disorder. Part I: Intervention and implementation in a randomized effectiveness trial. Psychiatric Services, 57, 927–936.

    Google Scholar 

  • Bauer, M. S., McBride, L., & Williford, W. O., et al. (2006b). Collaborative care for bipolar disorder. Part II: Impact on clinical outcome, function, and costs. Psychiatric Services, 57, 937–945.

    Google Scholar 

  • Belmaker, R. H. (2004). Bipolar disorder. New England Journal of Medicine, 351(5), 476–485.

    Article  CAS  PubMed  Google Scholar 

  • Belmaker, R. H. (2007). Treatment of bipolar depression. New England Journal of Medicine., 356(17), 1771–1773.

    Article  CAS  PubMed  Google Scholar 

  • Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. N Engl J Med, 358(1), 55–68. https://doi.org/10.1056/NEJMra073096. PMID: 18172175.

  • Belvederi Murri, M., Prestia, D., Mondelli, V., et al. (2016). The HPA axis in bipolar disorder: Systematic review and meta-analysis. Psychoneuroendocrinology, 63, 327–342.

    Article  CAS  PubMed  Google Scholar 

  • Berk, L., Hallam, K. T., Colom, F., Vieta, E., Hasty, M., Macneil, C., & Berk, M. (2010). Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacol, 25(1), 1–16. https://doi.org/10.1002/hup.1081. Erratum in: Hum Psychopharmacol. 2010 Mar;25(2):192.

  • Bhardwaj, R., Chakrabarti, S., & Mittal, B. R., et al. (2010). A single photon emission computerized tomography (SPECT) study of regional cerebral blood flow in bipolar disorder. World Journal of Biological Psychiatry, 11(2 Pt 2), 334–343.

    Google Scholar 

  • Birmaher, B., Axelson, D., Goldstein, B., et al. (2009). Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: The course and outcome of bipolar youth (COBY) study. The American Journal of Psychiatry, 166(7), 795–804.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bo, Q., Mao, Z., Li, X., et al. (2017). Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis. PLoS One, 12(4).

    Google Scholar 

  • Bolton, J. M., Robinson, J., & Sareen, J. (2009). Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on alcohol and related conditions. Journal of Affective Disorders, 115(3), 367–375.

    Article  PubMed  Google Scholar 

  • Carvalho, A. F., Firth, J., & Vieta, E. (2020). Bipolar disorder. New England Journal of Medicine, 383(1), 58–66.

    Article  CAS  PubMed  Google Scholar 

  • Cattarinussi, G., Di Giorgio, A., Wolf, R. C., et al. (2019). Neural signatures of the risk for bipolar disorder: A meta-analysis of structural and functional neuroimaging studies. Bipolar Disorders, 21(3), 215–227.

    Article  PubMed  Google Scholar 

  • Chandrasekaran, V., Brennan-Olsen, S. L., Stuart, A. L., et al. (2019). Bipolar disorder and bone health: A systematic review. Journal of Affective Disorders, 249, 262–269.

    Article  PubMed  Google Scholar 

  • Clarkin, J. F., Glick, I., & Haas, G., et al. (1990). A randomized clinical trial of inpatient family intervention. V. results for affective disorders. Journal of Affective Disorders, 18, 17–28.

    Google Scholar 

  • Clarkin, J. F., Carpenter, D., & Hull, J., et al. (1998). Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses. Psychiatric Services, 49, 531–533.

    Google Scholar 

  • Cochran, S. D. (1984). Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. Journal of Consulting and Clinical Psychology, 52, 873–878.

    Google Scholar 

  • Colom, F., Vieta, E., & Martinez-Aran, A., et al. (2003a). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry, 60, 402–407.

    Google Scholar 

  • Colom, F., Vieta, E., & Reinares, M., et al. (2003b). Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. Journal of Clinical Psychiatry, 64, 1101–1105.

    Google Scholar 

  • Cotovio, G., Talmasov, D., Barahona-Corea, B., et al. (2020). Mapping mania symptoms based on focal brain damage. Journal of Clinical Investigation., 130(10), 5209–5222.

    Article  PubMed  PubMed Central  Google Scholar 

  • DelBello, M. P., Goldman. R., & Phillips. D., et al. (2017). Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: A double-blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 56(12), 1015–1025. https://doi.org/10.1016/j.jaac.2017.10.006

  • Demissie, M., Hanlon, C., Birhane, R., et al. (2018). Psychological interventions for bipolar disorder in low- and middle-income countries: Systematic review. BJPsych Open, 4(5), 375–384.

    Article  PubMed  PubMed Central  Google Scholar 

  • El-Mallakh, P. (1998). Treatment models for clients with co-occurring addictive and mental disorders. Archives of Psychiatric Nursing, 12(2), 71–80.

    Article  CAS  PubMed  Google Scholar 

  • El-Mallakh, R. S., & Huff, M. O. (2001). Mood stabilizers and ion regulation. Harvard Review of Psychiatry, 9(1), 23–32.

    Article  CAS  PubMed  Google Scholar 

  • El-Mallakh, R. S., Ghaemi, S. N., Sagduyu, K., et al. (2008). Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients. Journal of Affective Disorders, 111(2–3), 372–377.

    Article  CAS  PubMed  Google Scholar 

  • El-Mallakh RS, Vöhringer PA, Ostacher MM, et al. (2015) Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial. Journal of Affective Disorders, 184, 318–321. [published correction appears in Journal of Affective Disorders 2016 190, 895].

    Google Scholar 

  • Ferrer, A., Costas, J., Gratacos, M., et al. (2020). Clock gene polygenic risk score and seasonality in major depressive disorder and bipolar disorder. Genes, Brain and Behavior, 19(8), e12683.

    Article  CAS  PubMed  Google Scholar 

  • Findling, R. L., McNamara, N. K., & Pavuluri, M., et al. (2019). Lithium for the maintenance treatment of bipolar I disorder: A double-blind, placebo-controlled discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry, 58(2), 287–296.e4. https://doi.org/10.1016/j.jaac.2018.07.901

  • Fornaro, M., Orsolini, L., Marini, S., et al. (2016). The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis. Journal of Affective Disorders, 195, 105–118.

    Article  CAS  PubMed  Google Scholar 

  • Fornaro, M., Carvlho, A. F., Fusco, A., et al. (2020). The concept and management of acute episodes of treatment-resistant bipolar disorder: A systematic review and exploratory meta-analysis of randomized controlled trials. Journal of Affective Disorders, 276, 970–983.

    Article  CAS  PubMed  Google Scholar 

  • Frank, E., Swartz, H., & Mallinger, A. G., et al. (1999). Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. Journal of Abnormal Psychology, 108, 579–587.

    Google Scholar 

  • Frank, E., Kupfer, D. J., & Thase, M. E., et al. (2005). Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Archives of General Psychiatry, 62, 996–1004.

    Google Scholar 

  • Galling, B., Garcia, M. A., & Osuchukwu, U., et al. (2015). Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis. Expert Opinion in Drug Safety, 14(8), 1181–1199. https://doi.org/10.1517/14740338.2015.1053457

  • Gao, Y., Lei, Z., Lu, C., Roisen, F. J., & El-Mallakh, R. S. (2010). Effect of ionic stress on apoptosis and the expression of TRPM2 in human olfactory neuroepithelial-derived progenitors. World Journal of Biological Psychiatry, 11(8), 972–984.

    Google Scholar 

  • Gao, Y., Lohano, K., Delamere, N. A., Lei, Z., & El-Mallakh, R. S. (2019). Ethanol normalizes glutamate-induced elevation of intracellular sodium in olfactory neuroepithelial progenitors from subjects with bipolar illness but not nonbipolar controls: Biologic evidence for the self-medication hypothesis. Bipolar Disorders, 21(2), 179–181.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ghaemi, S. N., Ostacher, M. M., El-Mallakh, R. S., et al. (2010). Antidepressant discontinuation in bipolar depression: A systematic treatment enhancement program for bipolar disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. Journal of Clinical Psychiatry, 71(4), 372–380.

    Article  PubMed  Google Scholar 

  • Gonul, A. S., Coburn, K., & Kula, M. (2009). Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: The role of PET and SPECT studies. International Review of Psychiatry, 21(4), 323–335.

    Article  PubMed  Google Scholar 

  • Goodwin, F. K., & Jamison, K. R. (2007). Depressive illness: Bipolar disorders and recurrent depression (2nd ed., p. 2007). Oxford University Press.

    Google Scholar 

  • Grant, B. F., Stinson, F. S., Hasin, D. S., et al. (2005). Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: Results from the National Epidemiologic Survey on alcohol and related conditions. Journal of Clinical Psychiatry, 66(10), 1205–1215.

    Article  PubMed  Google Scholar 

  • Grant, B. F., Chou, S. P., Goldstein, R. B., et al. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the wave 2 National Epidemiologic Survey on alcohol and related conditions. Journal of Clinical Psychiatry, 69(4), 533–545.

    Article  PubMed  Google Scholar 

  • Haggarty, S. J., Karmacharya, R., & Perlis, R. H. (2021). Advances toward precision medicine for bipolar disorder: Mechanisms & molecules. Molecular Psychiatry, 26(1), 168–185.

    Article  PubMed  Google Scholar 

  • Hajek, T., Bauer, M., Simhandl, C., et al. (2014). Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychological Medicine, 44(3), 507–517.

    Article  CAS  PubMed  Google Scholar 

  • He, H., Hu, C., Ren, Z., et al. (2020). Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of disease study 2017. Journal of Psychiatric Research, 125, 96–105.

    Article  PubMed  Google Scholar 

  • Healy, D. (2008). Mania: A short history of bipolar disorder. Johns Hopkins University Press.

    Book  Google Scholar 

  • Hernandez-Gomez, A., Andrade-Gonzalez, N., Lahera, G., et al. (2021). Recommendations for the care of patients with bipolar disorder during the COVID-19 pandemic. Journal of Affective Disorders, 297, 117–121.

    Article  Google Scholar 

  • Hodes, A., Rosen, H., Cohen-Ben Ami, H., & Lichtstein, D. (2019). Na+, K+-ATPase α3 isoform in frontal cortex GABAergic neurons in psychiatric diseases. Journal of Psychiatric Research, 115, 21–28.

    Article  PubMed  Google Scholar 

  • Jackson, D., Kolikonda, M. K., Yeruva, R. R., & El-Mallakh, R. S. (2018). Sexual behavior in patients with bipolar illness. Annals of Clinical Psychiatry, 30(4), 289–295.

    PubMed  Google Scholar 

  • Jauhar, S., Nour, M. M., Veronese, M., et al. (2017). A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry, 74(12), 1206–1213.

    Article  PubMed  PubMed Central  Google Scholar 

  • Johnson, S. L. (2005). Life events in bipolar disorder: towards more specific models. Clinical Psychology Review, 25, 1008–1027.

    Google Scholar 

  • Joshi, A., Bow, A., & Agius, M. (2019). Pharmacological Therapies in Bipolar Disorder: a Review of Current Treatment Options. Psychiatria Danubina, 31(Suppl 3), 595–603.

    Google Scholar 

  • Karow, A., Brettschneider, C., et al. (2020). Better care for less money: Cost-effectiveness of integrated care in multi-episode patients with severe psychosis. Acta Psychiatrica Scandinavica, 141(3), 221–230.

    Article  CAS  PubMed  Google Scholar 

  • Kessing, L. V., Vradi, E., & Andersen, P. K. (2015). Life expectancy in bipolar disorder. Bipolar Disorders, 17(5), 543–548. https://doi.org/10.1111/bdi.12296

  • Kishi T, Ikuta T, Matsuda Y, et al. (2020a). Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials. Molecular Psychiatry. In press.

    Google Scholar 

  • Kishi T, Matsuda Y, Sakuma K, et al. (2020b). Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis. Psychol Med. In press.

    Google Scholar 

  • Kraiss, J. T., Wijnen, B., Kupka, R. W., Bohlmeijer, E. T., & Lokkerbol, J. (2020). Economic evaluations of non-pharmacological interventions and cost-of-illness studies in bipolar disorder: A systematic review. Journal of Affective Disorders, 276, 388–401.

    Article  PubMed  Google Scholar 

  • Kreinin, A., Novitski, D., Rabinowitz, D., Weizman, A., & Grinshpoon, A. (2012). Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients. Compr Psychiatry, 53(3), 269–74. https://doi.org/10.1016/j.comppsych.2011.04.063

  • Lam, D. H., Bright, J., & Jones, S., et al. (2000). Cognitive therapy for bipolar illness – a pilot study of relapse prevention. Cognitive Therapy and Research, 24, 503–520.

    Google Scholar 

  • Lam, D. H., Watkins, E. R., & Hayward, P., et al. (2003). A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder. Outcome of the first year. Archives of General Psychiatry, 60, 145–152.

    Google Scholar 

  • Lam, D. H., Hayward, P., & Watkins, E. R., et al. (2005a). Relapse prevention in patients with bipolar disorder; cognitive therapy outcome after 2 years. American Journal of Psychiatry, 162, 324–329.

    Google Scholar 

  • Lam, D. H., McCrone, P., & Wright, K., et al. (2005b). Cost-effectiveness of relapse prevention cognitive therapy for bipolar disorder: 30-month study. British Journal of Psychiatry, 186, 500–506.

    Google Scholar 

  • Lee, Y., Brietzke, E., Cao, B., et al. (2020). Development and implementation of guidelines for the management of depression: A systematic review. Bulletin of the World Health Organization, 98, 683–697H.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lim, C. S., Baldessarini, R. J., Vieta, E., et al. (2013). Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: Review of the evidence. Neuroscience and Biobehavioral Reviews, 37(3), 418–435.

    Article  PubMed  Google Scholar 

  • Luykx, J. J., Giuliani, F., Giuliani, G., et al. (2019). Coding and non-coding RNA abnormalities in bipolar disorder. Genes (Basel), 10(11), 946.

    Article  CAS  PubMed  Google Scholar 

  • Mack, A., Gao, Y., Kakar, S., et al. (2019). Review of animal models of bipolar disorder that alter ion regulation. Neuroscience and Biobehavioral Reviews, 107, 208–214.

    Article  PubMed  PubMed Central  Google Scholar 

  • MacQueen, G. J., Hajek, T., & Alda, M. (2005). The phenotypes of bipolar disorder: Relevance for genetic investigations. Molecular Psychiatry, 10, 811–826.

    Article  CAS  PubMed  Google Scholar 

  • Madden, J. M., Araujo-Lane, C., Foxworth, P., et al. (2020). Experiences of health care costs among people with employer-sponsored insurance and bipolar disorder. Journal of Affective Disorders, 281, 41–50.

    Article  PubMed  Google Scholar 

  • Malhi, G. S., & Berk, M. (2012). Is the safety of lithium no longer in the balance? Lancet, 379, 690–692.

    Article  PubMed  Google Scholar 

  • McIntyre, R. S., Patel, M. D., Masand, P. S., et al. (2021). The rapid mood screener (RMS): A novel and pragmatic screener for bipolar I disorder. Current Medical Research and Opinion, 37(1), 135–144.

    Article  CAS  PubMed  Google Scholar 

  • McKnight, R. F., Adida, M., Budge, K., et al. (2012). Lithium toxicity profile: A systematic review and meta-analysis. Lancet, 379, 721–728.

    Article  CAS  PubMed  Google Scholar 

  • Meltzer-Brody, S., Colquhoun, H., Riesenberg, R., et al. (2018). Brexanolone injection in post-partum depression: Two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet, 392(10152), 1058–1070.

    Article  CAS  PubMed  Google Scholar 

  • Merikangas KR, Akiskal HS, Angst J, et al. (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Archives of General Psychiatry, 64(5), 543–552. (Erratum in Archives of General Psychiatry, 64(9), 1039).

    Google Scholar 

  • Miklowitz, D. J., Simoneau, T. L., & George, E. L., et al. (2000). Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biological Psychiatry, 48, 582–592.

    Google Scholar 

  • Miklowitz, D. J., George, E. L., & Richards, J. A., et al. (2003). A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Archives of General Psychiatry, 60, 904–912.

    Google Scholar 

  • Miller, J. N., & Black, D. W. (2020). Bipolar disorder and suicide: A review. Current Psychiatry Reports, 22(2), 6.

    Article  PubMed  Google Scholar 

  • Miller, I. W., Solomon, D. A., & Ryan, C. E., et al. (2004). Does adjunctive family therapy enhance recovery from bipolar I mood episodes? Journal of Affective Disorders, 82, 431–436.

    Google Scholar 

  • Minassian, A., Young, J. W., Geyer, M. A., et al. (2018). The COMT Val158Met polymorphism and exploratory behavior in bipolar mania. Molecular Neuropsychiatry, 3(3), 151–156.

    PubMed  Google Scholar 

  • Nicholas, J., Boydell, K., & Christensen, H. (2017). Beyond symptom monitoring: Consumer needs for bipolar disorder self-management using smartphones. European Psychiatry, 44, 210–216.

    Article  CAS  PubMed  Google Scholar 

  • Oedegaard, K. J., Alda, M., Anand, A., et al. (2016). The pharmacogenomics of bipolar disorder study (PGBD): Identification of genes for lithium response in a prospective sample. BMC Psychiatry, 16, 129.

    Article  PubMed  PubMed Central  Google Scholar 

  • Okbay, A., Beauchamp, J. P., Fontana, M. A., et al. (2016). Genome-wide association study identifies 74 loci associated with educational attainment. Nature, 26(533 [7604]), 539–542.

    Article  Google Scholar 

  • Pan, Y. J., Yeh, L. L., Chen, Y. C., et al. (2016). Hospital treatment, mortality and healthcare costs in relation to socioeconomic status among people with bipolar affective disorder. BJPsych Open, 2(1), 10–17.

    Article  PubMed  PubMed Central  Google Scholar 

  • Parmentier, T., & Sienaert, P. (2018). The use of triiodothyronine (T3) in the treatment of bipolar depression: A review of the literature. Journal of Affective Disorders, 229, 410–414.

    Article  CAS  PubMed  Google Scholar 

  • Perry, A., Tarrier, N., & Morriss, R., et al. (1999). Randomized controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ, 318, 149–153.

    Google Scholar 

  • Popovic, D., Reinares, M., Goikolea, J. M., et al. (2012). Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. European Neuropsychopharmacology, 22(5), 339–346.

    Article  CAS  PubMed  Google Scholar 

  • Post, R. M. (2021). The kindling/sensitization model and early life stress. Current Topics in Behavioral Neuroscience, 48, 255–275.

    Article  CAS  Google Scholar 

  • Post, R. M., Leverich, G. S., Altshuler, L. L., et al. (2011). Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany. International Clinical Psychopharmacology, 26(2), 96–106.

    Article  PubMed  Google Scholar 

  • Post, R. M., Altshuler, L. L., Kupka, R., et al. (2020). More assortative mating in US compared to European parents and spouses of patients with bipolar disorder: Implications for psychiatric illness in the offspring. European Archives of Psychiatry and Clinical Neuroscience, 270(2), 237–245.

    Article  PubMed  Google Scholar 

  • Raja, M., & Raja, S. (2014). Lithium treatment in elderly patients affected by mood disorders. Rivista di Psichiatria, 49(4), 180–182. https://doi.org/10.1708/1600.17456

  • Rea, M. M., Tompson, M. C., & Miklowitz, D. J., et al. (2003). Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. Journal of Consulting and Clinical Psychology, 3, 482–492.

    Google Scholar 

  • Ren, H., Guan, L., Zhao, L., et al. (2018). Contribution of genes in the GABAergic pathway to bipolar disorder and its executive function deficit in the Chinese Han population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177(1), 50–67.

    Article  CAS  Google Scholar 

  • Rhee, T. G., Olfson, M., Nierenberg, A. A., et al. (2020). 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings. American Journal of Psychiatry, 177(8), 706–715.

    Article  PubMed  Google Scholar 

  • Rush, A. J., Jr., First, M. B., & Blacker, D. (2007). Handbook of psychiatric measures (2nd ed.). American Psychiatric Press.

    Google Scholar 

  • Saha, S., Lim, C. C. W., Cannon, D. L., et al. (2020). Co-morbidity between mood and anxiety disorders: A systematic review and meta-analysis. Depression and Anxiety, 38(3), 286–306.

    Article  PubMed  PubMed Central  Google Scholar 

  • Saiyad, M., & El-Mallakh, R. S. (2012). Smoking is associated with greater symptom load in bipolar disorder patients. Ann Clin Psychiatry, 24(4), 305–9.

    Google Scholar 

  • Santos, R., Linker, S. B., Stern, S., et al. (2021). Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients. Molecular Psychiatry, 26(6), 2440–2456.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saraf, G., Moazen-Zadeh, E., Pinto, J. V., et al. (2021). Early intervention for people at high risk of developing bipolar disorder: A systematic review of clinical trials. Lancet Psychiatry, 8(1), 64–75.

    Article  PubMed  Google Scholar 

  • Schoeyen, H. K., Birkenaes, A. B., Vaaler, A. E., et al. (2011). Bipolar disorder patients have similar levels of education but lower socio-economic status than the general population. Journal of Affective Disorders, 129(1–3), 68–74.

    Article  PubMed  Google Scholar 

  • Scott, J., Garland, A., & Moorhead, S. (2001). A pilot study of cognitive therapy in bipolar disorders. Psychological Medicine, 31, 459–467.

    Google Scholar 

  • Scott, J., Paykel, E., Morriss, R., et al. (2006). Cognitive-behavioral therapy for bipolar disorder. British Journal of Psychiatry, 188, 488–489.

    Article  CAS  Google Scholar 

  • Sheehan, D. V., Harnett-Sheehan, K., & Hidalgo, R. B., et al. (2013). Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. Journal of Affective Disorders, 145(1), 83–94.

    Google Scholar 

  • Shobassy, A. (2021). Elderly bipolar disorder. Current Psychiatry Reports, 23(2), 5.

    Article  PubMed  Google Scholar 

  • Simon, G. E., Ludman, E. J., & Unützer, J., et al. (2005). Effectiveness of a population-based care program for people with bipolar disorder. Psychological Medicine, 35, 13–24.

    Google Scholar 

  • Simon, G. E., Ludman, E. J., & Bauer, M. S., et al. (2006). Long-term effectiveness and cost of a systematic care management program for bipolar disorder. Archives of General Psychiatry, 63, 500–508.

    Google Scholar 

  • Singh, N., Serres, F., Toker, L., et al. (2020). Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity. European Journal of Pharmacology, 883, 173377.

    Article  CAS  PubMed  Google Scholar 

  • Sleem, A., & El-Mallakh, R. S. (2021). Advances in the psychopharmacotherapy of bipolar disorder type I. Expert Opinion in Pharmacotherapy, 22(10), 1267–1290.

    Article  CAS  Google Scholar 

  • Stern, S., Sarkar, A., Stern, T., et al. (2020a). Mechanisms underlying the hyperexcitability of CA3 and dentate gyrus hippocampal neurons derived from bipolar disorder patients. Biological Psychiatry, 88(2), 139–149.

    Article  CAS  PubMed  Google Scholar 

  • Stern, S., Sarkar, A., Galor, D., et al. (2020b). A physiological instability displayed in hippocampal neurons derived from lithium non-responsive bipolar disorder patients. Biological Psychiatry, 88(2), 150–158.

    Article  CAS  PubMed  Google Scholar 

  • Suppes, T., Vieta, E., Gustafsson, U., et al. (2013). Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: Analysis of two large randomized, placebo-controlled trials. Depression and Anxiety, 30(11), 1089–1098.

    Article  CAS  PubMed  Google Scholar 

  • Teh, W. L., Abdin, E., Vaingankar, J., et al. (2020). Prevalence and correlates of bipolar spectrum disorders in Singapore: Results from the 2016 Singapore mental health study (SMHS 2016). Journal of Affective Disorders, 274, 339–346.

    Article  PubMed  Google Scholar 

  • Velosa, J., Delgado, A., Finger, E., et al. (2020). Risk of dementia in bipolar disorder and the interplay of lithium: A systematic review and meta-analyses. Acta Psychiatrica Scandinavica, 141(6), 510–521.

    Article  CAS  PubMed  Google Scholar 

  • Vieta, E., Salagre, E., Grande, I., et al. (2018a). Early intervention in bipolar disorder. American Journal of Psychiatry, 175(5), 411–426.

    Article  PubMed  Google Scholar 

  • Vieta, E., Berk, M., Schulze, T. G., et al. (2018b). Bipolar disorders. Nature Reviews Disease Primers, 4, 18008.

    Article  PubMed  Google Scholar 

  • Vo, D., & Dunner, D. L. (2003). Treatment-resistant bipolar disorder: a comparison of rapid cyclers and nonrapid cyclers. CNS Spectrums, 8(12), 948–952. https://doi.org/10.1017/s1092852900028716

  • Wang, K., Varma, D. S., & Prosperi, M. (2018). A systematic review of the effectiveness of mobile apps for monitoring and management of mental health symptoms or disorders. Journal of Psychiatric Research, 107, 73–78.

    Article  PubMed  Google Scholar 

  • Weiss, R. D., Griffin, M. L., & Kolodziej, M. E., et al. (2007). A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. American Journal of Psychiatry, 164, 100–107.

    Google Scholar 

  • Winokur, G., Clayton, P. J., & Reich, T. (1969). Manic-depressive illness. CV Mosby.

    Google Scholar 

  • Young, A. H., & Juruena, M. F. (2021). The neurobiology of bipolar disorder. Current Topics in Behavioral Neurosciences, 48, 1–20.

    CAS  PubMed  Google Scholar 

  • Young, A. H., Rigney, U., Shaw, S., Emmas, C., & Thompson, J. M. (2011). Annual cost of managing bipolar disorder to the UK healthcare system. J Affect Disord, 133(3), 450–6. https://doi.org/10.1016/j.jad.2011.06.016

  • Zhang, Y. S., Rao, W. W., Zeng, L. N., et al. (2020). Prevalence and correlates of bipolar disorder in the adult population of Hebei province, China. Journal of Affective Disorders, 263, 129–133.

    Article  PubMed  Google Scholar 

  • Zhang, C., Xiao, X., Li, T., et al. (2021). Translational genomics and beyond in bipolar disorder. Molecular Psychiatry, 26(1), 186–202.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rif S. El-Mallakh .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

El-Mallakh, R.S., Belmaker, R.H. (2023). Bipolar Disorder. In: Tasman, A., et al. Tasman’s Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-42825-9_19-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42825-9_19-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-42825-9

  • Online ISBN: 978-3-030-42825-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics